These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7934168)

  • 1. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
    Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
    Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
    Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P
    Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
    Han T; Fernandez M; Chou TC; Agarwal RP
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.
    Wright AM; Paterson AR; Sowa B; Akabutu JJ; Grundy PE; Gati WP
    Br J Haematol; 2002 Mar; 116(3):528-37. PubMed ID: 11849208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
    Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER
    Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
    Aleskog A; Larsson R; Höglund M; Sundström C; Kristensen J
    Eur J Haematol; 1999 May; 62(5):293-9. PubMed ID: 10359056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Csoka K; Liliemark J; Larsson R; Nygren P
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):47-53. PubMed ID: 7481845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Kristensen J; Sandberg C; Nygren P
    Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
    Kristensen J; Jonsson B; Sundström C; Nygren P; Larsson R
    Med Oncol Tumor Pharmacother; 1992; 9(2):65-74. PubMed ID: 1341718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Fridborg H; Kristensen J; Sundström C; Nygren P
    Br J Cancer; 1993 May; 67(5):969-74. PubMed ID: 8494730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
    Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
    Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
    Nagourney RA; Evans SS; Messenger JC; Su YZ; Weisenthal LM
    Br J Cancer; 1993 Jan; 67(1):10-4. PubMed ID: 8094002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
    Sawiński K; Hansz J; Kozłowska-Skrzypczak M
    Acta Haematol Pol; 1995; 26(3):279-84. PubMed ID: 8525773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
    Korycka A; Smolewski P; Robak T
    Eur J Haematol; 2004 Dec; 73(6):418-26. PubMed ID: 15522064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
    Klumper E; Ossenkoppele GJ; Pieters R; Huismans DR; Loonen AH; Rottier A; Westra G; Veerman AJ
    Br J Haematol; 1996 Jun; 93(4):903-10. PubMed ID: 8703824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia.
    Van Den Neste E; Martiat P; Mineur P; Delannoy A; Doyen C; Zenebergh A; Michaux JL; Ferrant A
    Ann Hematol; 1998 Jan; 76(1):19-23. PubMed ID: 9486920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
    Ehninger G; Proksch B; Wanner T; Schuler U; Busch FW; Schmidt H; Schleyer E; Jaschonek K; Hiddemann W
    Leukemia; 1992 Jun; 6(6):582-7. PubMed ID: 1602795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.